Related Experiment Videos
Prognostic factors in breast cancer
The British Journal of Surgery
|December 1, 1982
Summary
Clinical stage and tumor size are key factors in early breast cancer prognosis. Smaller tumors (≤2 cm) and specific age/menopausal groups show better survival rates, impacting treatment decisions.
Area of Science:
- Oncology
- Clinical Medicine
- Biostatistics
Background:
- Early breast cancer prognosis is influenced by multiple factors.
- Identifying key prognostic indicators is crucial for effective treatment planning.
- Previous studies have suggested various clinical and pathological factors impacting survival.
Purpose of the Study:
- To analyze prognostic factors in early breast cancer patients.
- To determine the significance of tumor size, patient age, menopausal status, and other variables on survival.
- To provide data for improved clinical decision-making in early breast cancer management.
Main Methods:
- Analysis of data from 1022 early breast cancer patients in a clinical trial.
- Statistical assessment of factors including clinical stage, tumor diameter, patient age, menopausal status, tumor site, marital status, and parity.
- Survival analysis to evaluate the impact of each factor on patient outcomes.
Main Results:
- Clinical stage was the most significant determinant of prognosis.
- Tumor size ≤2 cm was associated with significantly better survival compared to larger tumors.
- Patients aged 40-49 years and premenopausal patients had a relatively favorable prognosis.
- Tumor site, marital status, and number of pregnancies did not significantly influence prognosis.
Conclusions:
- Clinical stage and tumor size are paramount prognostic factors in early breast cancer.
- Age and menopausal status offer additional prognostic information.
- These findings can aid in risk stratification and personalized treatment strategies for early breast cancer.